Update on nephrogenic systemic fibrosis.

PubWeight™: 0.93‹?›

🔗 View Article (PMID 18926421)

Published in Magn Reson Imaging Clin N Am on November 01, 2008

Authors

Henrik S Thomsen1, Peter Marckmann, Vibeke B Logager

Author Affiliations

1: Department of Diagnostic Radiology, Copenhagen University Hospital Herlev, Herlev, Denmark. hentho01@heh.regionh.dk

Articles citing this

Advanced MRI methods for assessment of chronic liver disease. AJR Am J Roentgenol (2009) 1.39

Imaging of musculoskeletal soft tissue infections. Skeletal Radiol (2009) 1.21

Magnetic resonance angiography (MRA) of the calf station at 3.0 T: intraindividual comparison of non-enhanced ECG-gated flow-dependent MRA, continuous table movement MRA and time-resolved MRA. Eur Radiol (2011) 1.16

Decreased incidence of NSF in patients on dialysis after changing gadolinium contrast-enhanced MRI protocols. J Magn Reson Imaging (2010) 1.06

Diagnosis of liver metastases: value of diffusion-weighted MRI compared with gadolinium-enhanced MRI. Eur Radiol (2010) 0.96

Gadolinium-induced nephrogenic systemic fibrosis: the rise and fall of an iatrogenic disease. Clin Kidney J (2012) 0.85

Human brain tumor imaging with a protein-binding MR contrast agent: initial experience. Eur Radiol (2009) 0.85

Design of targeted cardiovascular molecular imaging probes. J Nucl Med (2010) 0.84

Diffusion-weighted imaging of the liver: an update. Cancer Imaging (2013) 0.82

Angiotensin-converting enzyme inhibitor-enhanced MR renography: repeated measures of GFR and RPF in hypertensive patients. Am J Physiol Renal Physiol (2009) 0.80

Preliminary assessment of cardiac short term safety and efficacy of manganese chloride for cardiovascular magnetic resonance in humans. J Cardiovasc Magn Reson (2011) 0.79

Cerebral perfusion changes in migraineurs: a voxelwise comparison of interictal dynamic susceptibility contrast MRI measurements. Cephalalgia (2012) 0.77

Assessment of the Focal Hepatic Lesions Using Diffusion Tensor Magnetic Resonance Imaging. J Med Signals Sens (2016) 0.75

Articles by these authors

[Nine reasons not to recommend protein rich diet]. Ugeskr Laeger (2013) 3.23

[A scientific evaluation of the "alternative" food pyramid]. Ugeskr Laeger (2005) 2.04

High prevalence of nephrogenic systemic fibrosis in chronic renal failure patients exposed to gadodiamide, a gadolinium-containing magnetic resonance contrast agent. Invest Radiol (2008) 1.38

Effects of unsaturated fat dietary supplements on blood lipids, and on markers of malnutrition and inflammation in hemodialysis patients. J Ren Nutr (2009) 1.09

Vitamin D status in kidney transplant patients: need for intensified routine supplementation. Am J Clin Nutr (2008) 1.01

No difference between alfacalcidol and paricalcitol in the treatment of secondary hyperparathyroidism in hemodialysis patients: a randomized crossover trial. Kidney Int (2011) 0.95

Effect of fish oil versus corn oil supplementation on LDL and HDL subclasses in type 2 diabetic patients. Diabetes Care (2002) 0.95

Extracellular Gd-CA: differences in prevalence of NSF. Eur J Radiol (2008) 0.94

Nephrogenic systemic fibrosis (NSF): a late adverse reaction to some of the gadolinium based contrast agents. Cancer Imaging (2007) 0.94

Multiorgan gadolinium (Gd) deposition and fibrosis in a patient with nephrogenic systemic fibrosis--an autopsy-based review. Nephrol Dial Transplant (2011) 0.93

Effect of garlic (Allium sativum) powder tablets on serum lipids, blood pressure and arterial stiffness in normo-lipidaemic volunteers: a randomised, double-blind, placebo-controlled trial. Br J Nutr (2004) 0.90

Plasma concentrations of extracellular matrix protein fibulin-1 are related to cardiovascular risk markers in chronic kidney disease and diabetes. Cardiovasc Diabetol (2013) 0.89

Unenhanced MR Imaging in adults with clinically suspected acute appendicitis. Eur J Radiol (2010) 0.84

Whole-body magnetic resonance angiography at 3 tesla using a hybrid protocol in patients with peripheral arterial disease. Cardiovasc Intervent Radiol (2009) 0.82

Nephrogenic systemic fibrosis: late skin manifestations. Arch Dermatol (2009) 0.80

MRI contrast media are used to improve visualization of abnormal structures or lesions in various parts of the body. Introduction. Eur J Radiol (2008) 0.78

Vitamin D status in children and adolescents with kidney transplants. Pediatr Transplant (2011) 0.77

A high fat meal activates blood coagulation factor VII in rats. J Nutr (2002) 0.77

Cancer rates after kidney transplantation. Dan Med Bull (2011) 0.76

Different effects of diets rich in olive oil, rapeseed oil and sunflower-seed oil on postprandial lipid and lipoprotein concentrations and on lipoprotein oxidation susceptibility. Br J Nutr (2002) 0.76

[Children, fat and cardiovascular diseases]. Ugeskr Laeger (2002) 0.76

Fishing for heart protection. Am J Clin Nutr (2003) 0.75

[Reply: Diogenes study does not show weight loss]. Ugeskr Laeger (2013) 0.75

[Healthy and sustainable diet is the goal]. Ugeskr Laeger (2013) 0.75

[Do fish and omega-3 fatty acid prevent heart disease?]. Ugeskr Laeger (2005) 0.75

Nephrogenic systemic fibrosis: a serious iatrogenic disease of renal failure patients. Scand J Urol Nephrol (2007) 0.75

Vitamin d and stage 5 chronic kidney disease: a new paradigm? Semin Dial (2011) 0.75

Feeding minipigs fish oil for four weeks lowers postprandial triacylglycerolemia. J Nutr (2003) 0.75

[Kidney function and immunosuppression of kidney-transplanted patients]. Ugeskr Laeger (2008) 0.75

[DANAMI-2: no basis for improved survival in primary angioplasty]. Ugeskr Laeger (2003) 0.75

[Olive oil can prevent cancer--a comment]. Ugeskr Laeger (2007) 0.75

[Calciphylaxis]. Ugeskr Laeger (2009) 0.75

Renal amyloid A amyloidosis as a complication of hidradenitis suppurativa. Clin Nephrol (2016) 0.75

Impact of vitamin D status and obesity on C-reactive protein in kidney-transplant patients. J Ren Nutr (2008) 0.75

[Doubt about the harmlessness of statins]. Ugeskr Laeger (2003) 0.75